封面
市場調查報告書
商品編碼
1387183

心導管電氣燒灼術市場報告:2030 年趨勢、預測與競爭分析

Cardiac Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

心導管電氣燒灼術趨勢和預測

預計到 2030 年,全球心導管電氣燒灼術市場將達到 89 億美元,2024 年至 2030 年年複合成長率為 13.0%。這個市場的主要促進因素是心血管患者數量眾多、醫療基礎設施的改善導致人們對更好的醫療服務的意識增強,以及久坐生活方式的採用。全球心導管電氣燒灼術市場的未來前景廣闊,外科中心、心臟中心和醫院市場充滿機會。

心導管電氣燒灼術市場洞察

Lucintel 預測,由於擴大採用先進的治療方法來治療慢性心臟疾病,電消融器將在預測期內實現最高的成長。

由於新興經濟體擴大尋求有效的治療解決方案,心臟中心仍然是市場中最大的部分。

由於人口老化迅速增加、心血管疾病盛行率上升以及該地區醫療保健產業的成長,預計亞太地區將在預測期內實現最高成長。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2. 未來哪個細分市場成長較快?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球心導管電氣燒灼術市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球心導管電氣燒灼術市場趨勢(2018-2023)與預測(2024-2030)
  • 按產品分類的全球心導管電氣燒灼術市場
    • 無線電頻率
    • 燒蝕器
    • 電燒灼
    • 冷凍裝置
    • 超音波消融儀
  • 按方法分類的全球心導管電氣燒灼術市場
    • 導管底座
    • 切開/手術
  • 按最終用途分類的全球心導管電氣燒灼術市場
    • 手術中心
    • 心臟中心
    • 醫院
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球心導管電氣燒灼術市場區域分佈
  • 北美心導管電氣燒灼術市場
  • 歐洲心導管電氣燒灼術市場
  • 亞太心導管電氣燒灼術市場
  • 其他區域心導管電氣燒灼術市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球心導管電氣燒灼術市場成長機會
    • 全球心導管電氣燒灼術市場成長機會(按方法)
    • 按最終用途分類的全球心導管電氣燒灼術市場成長機會
    • 按地區分類的全球心導管電氣燒灼術市場成長機會
  • 全球心導管電氣燒灼術市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球心導管電氣燒灼術市場的產能
    • 全球心導管電氣燒灼術市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • lcon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation
簡介目錄

Cardiac Ablation Trends and Forecast

The future of the global cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets. The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030 with a CAGR of 13.0% from 2024 to 2030. The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

A more than 150-page report is developed to help in your business decisions.

Cardiac Ablation by Segment

The study includes a forecast for the global cardiac ablation by product, approach, end use, and region.

Cardiac Ablation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Radiofrequency
  • Ablators
  • Electrical Ablators
  • Cryoablation Devices
  • Ultrasound Ablators

Cardiac Ablation Market by Approach [Shipment Analysis by Value from 2018 to 2030]:

  • Catheter-Based
  • Open/Surgical

Cardiac Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Surgical Centers
  • Cardiac Centers
  • Hospitals
  • Others

Cardiac Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cardiac Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac ablation companies profiled in this report include-

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Cardiac Ablation Market Insights

Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Within this market, cardiac centers will remain the largest segment due to rising deployment across developing economies for effective treatment solutions.

APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Features of the Global Cardiac Ablation Market

Market Size Estimates: Cardiac ablation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac ablation market size by product, approach, end use, and region in terms of value ($B).

Regional Analysis: Cardiac ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, approachs, end uses, and regions for the cardiac ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cardiac ablation market size?

Answer: The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030.

Q2. What is the growth forecast for cardiac ablation market?

Answer: The global cardiac ablation market is expected to grow with a CAGR of 13.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cardiac ablation market?

Answer: The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

Q4. What are the major segments for cardiac ablation market?

Answer: The future of the cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets.

Q5. Who are the key cardiac ablation market companies?

Answer: Some of the key cardiac ablation companies are as follows:

  • Icon Laboratories
  • Advanced Cardiac Therapeutics
  • Angiodynamics
  • Atricure
  • Biosense Webster
  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic
  • Olympus Corporation

Q6. Which cardiac ablation market segment will be the largest in future?

Answer: Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Q7. In cardiac ablation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cardiac ablation market by product (radiofrequency, ablators, electrical ablators, cryoablation devices, and ultrasound ablators), approach (catheter-based and open/surgical), end use (surgical centers, cardiac centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Ablation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cardiac Ablation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cardiac Ablation Market by Product
    • 3.3.1: Radiofrequency
    • 3.3.2: Ablators
    • 3.3.3: Electrical Ablators
    • 3.3.4: Cryoablation Devices
    • 3.3.5: Ultrasound Ablators
  • 3.4: Global Cardiac Ablation Market by Approach
    • 3.4.1: Catheter-Based
    • 3.4.2: Open/Surgical
  • 3.5: Global Cardiac Ablation Market by End Use
    • 3.5.1: Surgical Centers
    • 3.5.2: Cardiac Centers
    • 3.5.3: Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cardiac Ablation Market by Region
  • 4.2: North American Cardiac Ablation Market
    • 4.2.2: North American Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.3: European Cardiac Ablation Market
    • 4.3.1: European Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.3.2: European Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.4: APAC Cardiac Ablation Market
    • 4.4.1: APAC Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.4.2: APAC Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
  • 4.5: ROW Cardiac Ablation Market
    • 4.5.1: ROW Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
    • 4.5.2: ROW Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cardiac Ablation Market by Product
    • 6.1.2: Growth Opportunities for the Global Cardiac Ablation Market by Approach
    • 6.1.3: Growth Opportunities for the Global Cardiac Ablation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Cardiac Ablation Market by Region
  • 6.2: Emerging Trends in the Global Cardiac Ablation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cardiac Ablation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Ablation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: lcon Laboratories
  • 7.2: Advanced Cardiac Therapeutics
  • 7.3: Angiodynamics
  • 7.4: Atricure
  • 7.5: Biosense Webster
  • 7.6: Boston Scientific Corporation
  • 7.7: Conmed Corporation
  • 7.8: Medtronic
  • 7.9: Olympus Corporation